newwin
Luciann Nguyen
Settings
← Accounts
academic

Royal Marsden NHS Foundation Trust

70
Account opportunity
Not established
Relationship
1
Active signals
1
Trials as sponsor

Why this account matters

70/100
Opportunity
Commercial fit23/25
Clinical timing13/20
Biomarker need15/20
Relationship2/10
Signal strength9/10
Account value7/10
Urgency1/5

New unknown trial NCT04050345 posted by Royal Marsden NHS Foundation Trust: "Tracking Mutations in Cell Free Tumour DNA to Predict Relapse in Early Colorectal Cancer". New trial on a unknown recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).

Why nowClinicalTrials.gov record updated 816 days ago.

ConfidenceHigh · 95%clinical development · translational medicine · clinical operations

NextMap clinical development and translational medicine stakeholders on the sponsor, confirm no colleague is mid-conversation, then draft evidence-based outreach.

Trials

TrialPhaseTesting language
NCT04050345
Tracking Mutations in Cell Free Tumour DNA to Predict Relapse in Early Colorectal Cancer
unknown
ctDNA